2 Occam Court
Surrey Research Park
Guildford, Surrey
GU2 7QB
United Kingdom
Tel: +44 1483 595 000
Fax: +44 1483 595 001
4th Floor, Pembroke Building
Kensington Village
Avonmore Road
London, W14 8DG
United Kingdom
Tel: +44 207 565 8620
Fax: +44 207 565 8700
18 Rue Pasquier,
Paris, 75008
France
Tel: +33 01 78 41 44 46
1301 Marina Village Parkway
Suite 320,
Alameda, CA 94501
Tel: +1 510 814 4900
Fax: +1 510 814 4910
750 US Highway 202,
Suite 200,
Bridgewater, NJ 08807
Tel: +1 908 429 2900
Fax: +1 908 429 2901
25 Burlington Mall Road
1st Floor, Suite #107
Burlington, MA 01803
Tel: +1 781 272 3355
Fax: +1 781 272 3377
8770 W. Bryn Mawr,
Suite 1300,
Chicago, IL 60631
Tel: +1 773 867 2958
Shibuya Mark City W22F
1-12-1 Dogenzaka Shibuya-ku Tokyo
150-0043 Japan
Tel: +81 3 4360 5344
info-japan@idbs.com
Tel: +91-990-0064-922
+91-080-2587-0336
Room 207, Block A, Innovation Building
NO.333 Cailun Road, Zhangjiang High Tech. Park
Shanghai 201203
China
Tel: +86-21-6468-5535/6469-1770
Fax: +86-21-6468-5366
Conor Higgins
PO box 9079
Brighton
Melbourne
Vic 3186
Conor Higgins - chiggins@idbs.com
Tel: +61 410 708 052
Date: April 26, 2012 | Category: General News
Date: April 25, 2012 | Category: General News
Date: March 28, 2012 | Category: Personalized Medicine
Date: February 16, 2012 | Category: General News
Date: January 20, 2012 | Category: General News
Date: January 13, 2012 | Category: General News
Date: December 15, 2011 | Category: Personalized Medicine
Date: December 8, 2011 | Category: Personalized Medicine
Date: December 6, 2011 | Category: General News
Date: October 26, 2011 | Category: General News
Date: October 19, 2011 | Category: Personalized Medicine
Date: October 11, 2011 | Category: General News
Date: September 20, 2011 | Category: General News
Date: September 14, 2011 | Category: Personalized Medicine
Date: September 8, 2011 | Category: General News
Date: September 6, 2011 | Category: General News
Date: August 8, 2011 | Category: General News
Date: July 19, 2011 | Category: General News
Date: July 14, 2011 | Category: General News
Date: June 13, 2011 | Category: Pharmaceutical R&D, Personalized Medicine
Date: June 9, 2011 | Category: Pharmaceutical R&D, Personalized Medicine
Date: June 1, 2011 | Category: Pharmaceutical R&D
Date: May 25, 2011 | Category: Pharmaceutical R&D
Date: May 4, 2011 | Category: Pharmaceutical R&D, Industrials R&D
Date: April 21, 2011 | Category: General News
Date: April 4, 2011 | Category: Pharmaceutical R&D
Date: April 6, 2011 | Category: Pharmaceutical R&D, Personalized Medicine
Date: March 29, 2011 | Category: Personalized Medicine
Date: March 9, 2011 | Category: Personalized Medicine
Date: February 22, 2011 | Category: Pharmaceutical R&D
Date: February 22, 2011 | Category: Personalized Medicine
Date: February 17, 2011 | Category: General News
Date: February 1, 2011 | Category: Pharmaceutical R&D, Industrials R&D
Date: January 31, 2011 | Category: General News
Date: January 27, 2011 | Category: General News
Date: January 26, 2011 | Category: Pharmaceutical R&D
Date: January 13, 2011 | Category: Pharmaceutical R&D
Date: January 5, 2011 | Category: Pharmaceutical R&D, Industrials R&D
Date: November 10, 2010 | Category: General News
Date: November 10, 2010 | Category: Pharmaceutical R&D
Date: October 5, 2010 | Category: Personalized Medicine
Date: October 4, 2010 | Category: Personalized Medicine
Date: September 21, 2010 | Category: Personalized Medicine
Date: September 21, 2010 | Category: Personalized Medicine
Date: September 14, 2010 | Category: General News
Date: August 26, 2010 | Category: General News
Date: August 16, 2010 | Category: General News
Date: July 30, 2010 | Category: Pharmaceutical R&D
Date: June 30, 2010 | Category: Personalized Medicine
Date: June 2, 2010 | Category: General News
Date: May 24, 2010 | Category: Personalized Medicine
Date: May 6, 2010 | Category: General News
Date: April 14, 2010 | Category: Pharmaceutical R&D
Date: April 2, 2010 | Category: General News
Date: March 25, 2010 | Category: Pharmaceutical R&D
Date: March 17, 2010 | Category: Industrials R&D
Date: March 2, 2010 | Category: Pharmaceutical R&D
Date: February 23, 2010 | Category: Personalized Medicine
Date: February 17, 2010 | Category: Pharmaceutical R&D
Date: February 9, 2010 | Category: Personalized Medicine
Date: February 8, 2010 | Category: Personalized Medicine
Date: January 28, 2010 | Category: Personalized Medicine
Date: January 14, 2010 | Category: Pharmaceutical R&D
Date: January 7, 2010 | Category: Pharmaceutical R&D
Date: December 15, 2009 | Category: General News
Date: December 10, 2009 | Category: Pharmaceutical R&D
Date: December 7, 2009 | Category: Pharmaceutical R&D
Date: December 2, 2009 | Category: Pharmaceutical R&D
Date: November 10, 2009 | Category: General News
Date: October 21, 2009 | Category: Personalized Medicine
Date: October 21, 2009 | Category: Personalized Medicine
Date: September 25, 2009 | Category: Pharmaceutical R&D
Date: August 4, 2009 | Category: Industrials R&D
Date: June 26, 2009 | Category: Personalized Medicine
Date: June 1, 2009 | Category: Pharmaceutical R&D
Date: May 27, 2009 | Category: General News
Date: May 19, 2009 | Category: Pharmaceutical R&D
Date: April 28, 2009 | Category: Pharmaceutical R&D
Date: April 8, 2009 | Category: General News
Date: April 2, 2009 | Category: Pharmaceutical R&D
Date: January 5, 2009 | Category: Pharmaceutical R&D
Date: January 10, 2009 | Category: General News
Date: January 6, 2009 | Category: Pharmaceutical R&D
Date: December 10, 2008 | Category: Pharmaceutical R&D
Date: December 2, 2008 | Category: Personalized Medicine
Date: November 10, 2008 | Category: Pharmaceutical R&D
Date: October 30, 2008 | Category: Pharmaceutical R&D
Date: October 23, 2008 | Category: Pharmaceutical R&D
Date: September 26, 2008 | Category: Pharmaceutical R&D
Date: July 21, 2008 | Category: Pharmaceutical R&D
Date: July 15, 2008 | Category: Industrials R&D
Date: June 17, 2008 | Category: General News
Date: June 10, 2008 | Category: General News
Date: April 9, 2008 | Category: Pharmaceutical R&D
Date: April 1, 2008 | Category: General News
Date: February 11, 2008 | Category: Pharmaceutical R&D
Date: January 28, 2008 | Category: Pharmaceutical R&D
Date: December 5, 2007 | Category: Pharmaceutical R&D
Date: November 26, 2007 | Category: Pharmaceutical R&D
Date: November 14, 2007 | Category: Industrials R&D
Date: October 18, 2007 | Category: Pharmaceutical R&D
Date: October 2, 2007 | Category: Pharmaceutical R&D
Date: September 11, 2007 | Category: Pharmaceutical R&D
Date: July 11, 2007 | Category: Pharmaceutical R&D
Date: June 1, 2007 | Category: Pharmaceutical R&D
Date: May 22, 2007 | Category: Industrials R&D
Date: May 15, 2007 | Category: General News
Date: April 16, 2007 | Category: Pharmaceutical R&D
Date: January 31, 2007 | Category: Pharmaceutical R&D
Date: January 29, 2007 | Category: Pharmaceutical R&D
Date: November 16, 2006 | Category: Pharmaceutical R&D
Date: September 18, 2006 | Category: Pharmaceutical R&D
Date: September 8, 2006 | Category: Pharmaceutical R&D
Date: May 9, 2006 | Category: Pharmaceutical R&D
Date: May 3, 2006 | Category: Pharmaceutical R&D
Date: April 10, 2006 | Category: Pharmaceutical R&D
Date: April 3, 2006 | Category: Pharmaceutical R&D
2012
A leading ballet conductor1 recently told me of courses which he runs for senior business leaders. He allows them to conduct an orchestra: first, very strictly, with close direction applied to each instrument; he then shows them how to conduct the same score but harnessing the artistic talent of each group of players, encouraging active listening to each other – and then adding a conductor’s overall interpretation. This model of active collaboration between multi-skilled players on a managed platform provides a fascinating and revealing insight that has great relevance in the life sciences, particularly in today’s world of change.
April 2012
April 2012
NASA has used software provided by IDBS to analyse hundreds of thousands of data points that enable it to predict the power requirements for a 2012 space mission to Mars.
April 2012
In any ecosystem there exists multiple interdependent relationships, niches, and environmental pressures. In all ecosystems there are food chains that convert energy from simple to increasingly complex states. This metaphor is absolutely applicable to the data-driven environment of life sciences and healthcare R&D, where the efficient generation of complex information assets is key to success.
March 2012
The platform will allow KHP to combine clinical, genetic, and tissue sample data from more than 26,000 breast cancer patients as well as incorporate data from newly consented patients.
March 2012
U.K.-based King’s Health Partners has deployed the Oncology Research Information System (ORIS), an enterprise translational medicine platform provided by IDBS.
March 2012
IDBS, a small UK technology firm, believes it could be well placed to profit from the demise of blockbuster drugs.
January 2012
MA Governor Deval Patrick was on-hand to celebrate with IDBS and UKTI officers.
Read the article and watch the video here
January 2012
Financial Mail launches a regular series highlighting private companies blazing a trail in their sector through innovation, excellence or sheer hard work. IDBS is one to watch.
December 2011
Windber Research Institute’s information technology team has tapped into its expertise in medical research to develop a system that has gained international recognition.
December 2011
Autumn 2011
A new extension to the IDBS E-WorkBook – the electronic lab notebook (ELN) we use here in the department – makes it easy for chemists to send novel structures to the ChemSpider database.
November 2011
With electronic lab notebooks finally making waves in academia, Anthony King asks whether the time has come to part company with the much loved paper lab book.
October 2011
Chris Molloy, VP of Corporate Development, discusses trends in the pharmaceutical industry and data management requirements faced by bioanalytical scientists. The interview covers how IDBS E-WorkBook can dramatically improve information capture and analysis, and expedite reporting in bioanalytical laboratories.
August 2011
Find out how you can achieve more than 40% improvements in operational efficiency and greater than 70% reductions in QA overheads with IDBS Bioprocess Execution System.
August 2011
Dr. Howard Harvey, Senior Consultant at IDBS, is interviewed on his views of software requirements for forensics labs.
June 2011
The UK-based data management, analytics, and solutions firm was chosen by the Technology Strategy Board for the project, and will head a consortium called Tumor Profiling and Data Capture. Hosting firm Quantix and cancer centers at Kings Health Partners and Manchester Academic Health Science Center are also part of the consortium.
June 2011
Acquisition of InforSense Laid Groundwork for New Phenotypic- and Genomic-Focused Product.
June 2011
The Tumour Profiling and Data Capture consortium — composed of IDBS; cloud computing provider Quantix; and cancer centers at Kings Health Partners and Manchester Academic Health Science Center — plan to build a platform dubbed Acropolis, short for "Advanced Collaborative Research for Oncology Platform for Improved Outcomes, Learnings, Insight, and Science."
May 2011
The route to faster IND preparation requires turning to a data versus document approach.
April 2011
This interview with Neil Kipling, founder and CEO of IDBS, details the company’s recent success in winning the Queen’s Awards for International Trade 2011 and explains plans for business expansion.
April 2011
IDBS in March announced the deployment of a unique, enterprise translational medicine platform for the Integrated Cancer Centre at King’s Health Partners in the United Kingdom.
April/May 2011
In this article, Chris Molloy, VP of Corporate Development at IDBS, delivers his expertise on the changing informatics landscape within the pharmaceutical industry. He explains how IDBS applications ensure quality and context around scientific information across the enterprise to enable customers to have real-time insight into their R&D processes.
February/March 2011
Scientists are developing iPhone apps that aid in research and that appeal to "citizen scientists" as well.
February/March 2011
Bringing a new drug to market is a costly and time consuming endeavor. To streamline this process and submit an IND ahead of the competition, pharmaceutical companies are increasingly turning to outsourcing.
In this article, Chris Molloy, VP of Corporate Development at IDBS, is asked for his views regarding the CRO market. He explains how IDBS applications are being used as data collaboration centers supporting multiple domains. This streamlines operations, improves data security and ensures industry standard services for CROs and their sponsors.
February 2011
Pharmaceutical companies invest considerable time and money generating high-value data throughout the development life cycle. This information is often locked in paper records or isolated electronic files, across multiple locations and in different formats, making it difficult to manage and analyze process data efficiently.
Lonza has selected IDBS’ Bioprocess Execution System (BPES) to streamline and optimize the management of their process development data. The application allows data to be stored in context and more effectively shared between groups, deployed as a source of corporate knowledge, and used to monitor and improve process development and biological production operations.
January 2011
With Electronic Laboratory Notebooks now used in an increasing variety of applications throughout biological and life science applications, users now expect much more than a simple paper replacement. Exploring the wide range of domains now utilising ELN technology, pioneering uses of ELNs are investigated including seamless integration with existing data stores and instrumentation and the importance of providing a suitable platform which can be applied to multiple applications.
The article details the real-world application of IDBS' E-WorkBook to enable real-time Quality By Design (QbD) allowing users to resolve issues rapidly and without significant downtime.
December 2010
IDBS developed E-WorkBook for biology to meet experimental design, organization, and data management needs in life science discovery and pharmaceutical research and development.
October 2010
IDBS has been shortlisted in the Company of the Year category at the Growing Business Awards 2010, hosted by the CBI and Real Business. This article demonstrates IDBS' stunning achievements in a huge, global marketplace.
October 2010
The petrochemical industry faces many challenges in terms of speeding up analysis of test results, and streamlining processes to ensure fast and reliable decision-making. Data management platforms help petrochemical companies meet the high demand for their output, with companies such as IDBS providing efficient and flexible solutions to ensure data quality and simplify the production process.
This article demonstrates how IDBS' E-WorkBook for Chemistry is being used to accelerate processes and improve efficiency and productivity at Total Petrochemicals.
October 2010
Genomic Health is using IDBS' E-WorkBook and InforSense Suites for its new clinical research data management and decision-capture platform. This article demonstrates how IDBS' solutions are used to enhance genomic-based clinical laboratory services for cancer.
August 2010
Human health research uses genomic technologies to gain a better understanding of the genetics behind certain conditions. Research centers will tap into clinical samples stored in biorepositories and conduct genotyping to search for any genetic variations that could be linked to the disease.
This article discusses IDBS' laboratory informatics solutions in the field of genomics and details how IDBS' InforSense Suite is ideally suited to integrate genomics and clinical data. Jonathan Sheldon, Director of Translational Medicine at IDBS, provides his expertise.
July 2010
Workflow platforms have evolved through improved collaboration capabilities, many more analytics, links to electronic lab notebooks, expanded scientific data search, and expanded networks of third-party point tools, web enablement, and improved GUIs.
This article explores how IDBS' InforSense Suite provides a sophisticated analytics and integration framework to enable data management, business process management, and data deployment across the enterprise. This ensures organizations can rapidly access relevant clinical, sample, and research data, streamlining analysis and ultimately speeding discovery into therapeutics.
Summer 2010
The route to faster IND preparation requires turning to a data versus document approach.
June 2010
There are significant data management challenges facing biotechnology companies which are different to those faced in the development of traditional, small molecule therapeutics. This article explores these differences and how a major US biotech company is using E-WorkBook to streamline workflows and effectively manage complex and diverse data.
April 2010
Biorepositories provide a resource for researchers to increase understanding of complex diseases. Studies such as the Lung Genomics Research Consortium (LGRC) are going a step further than standard biobanking practices and characterizing the samples with their molecular makeup. The molecular data can then be mined along with the clinical data.
IDBS is working with the Dana-Farber Cancer Institute to help the LGRC to manage and analyze their phenotypic and genomic data with the Biomarker Discovery and Validation Solution.
April 2010
Biopharmaceutical firm Shire will use IDBS' E-WorkBook Suite to support a virtual model for pharmaceutical research. This article demonstrates the benefits of using IDBS technologies as hosted solutions, to capture, store and review data as well as protect IP.
February 2010
Electronic health records, when paired with genomic information, may pave the way for a healthcare revolution. This article features IDBS customer John Quackenbush of Dana-Farber Cancer Institute and discusses the future of personalized medicine.
February 11, 2010
Dana-Farber's Center for Cancer Computational Biology is using IDBS as part of the data coordination and analysis infrastructure for the Lung Genomics Research Consortium to advance research of chronic obstructive pulmonary disease, pulmonary fibrosis, and other chronic lung diseases.
January 8, 2010
ActivityBase XE is being used by leading Contract Research Organizations to deliver industry standard screening solutions. This article demonstrates how IDBS is accelerating the translation of research from academic institutes and universities across Europe to deliver commercial quality screening results.
October 30, 2009
IDBS completed its acquisition of InforSense in June 2009. This article explains how IDBS and InforSense solutions are fully complementary and can provide complete and robust data analysis across life science, translational research and academia.
July 16, 2009
This article highlights how pharmaceutical companies are implementing leading edge informatics tools to automate and accelerate biomarker discovery and validation.
Summer 2009
Integrating LIMS and ELNs can provide a platform to manage R&D and instrument data across departments, making information accessible throughout an organization. This article discusses the functionality and relative merits of LIMS and ELNS and explains how these technologies can be complementary.
June 1, 2009
This article demonstrates how Genmab are relying on ActivityBase XE to capture, validate and visualize screening data of monoclonal antibodies. Using ActivityBase, Genmab can analyze results from its discovery activities and target specific antigens involved in the pathology of disease.
May 18, 2012 | Category: Personalized Medicine
May 17, 2012 | Category: Personalized Medicine
May 17, 2012 | Category: Pharmaceutical R&D
May 16, 2012 | Category: Personalized Medicine
May 15, 2012 | Category: Personalized Medicine
May 15, 2012 | Category: Personalized Medicine
May 14, 2012 | Category: Pharmaceutical R&D
May 11, 2012 | Category: Industrials R&D
May 11, 2012 | Category: Pharmaceutical R&D
May 10, 2012 | Category: Industrials R&D
May 9, 2012 | Category: Personalized Medicine
May 9, 2012 | Category: Personalized Medicine
May 8, 2012 | Category: Personalized Medicine
May 4, 2012 | Category: Personalized Medicine
May 3, 2012 | Category: Personalized Medicine
May 2, 2012 | Category: Pharmaceutical R&D
May 2, 2012 | Category: Personalized Medicine
April 30, 2012 | Category: Personalized Medicine
May 1, 2012 | Category: Pharmaceutical R&D
May 1, 2012 | Category: Personalized Medicine
" IDBS products provide a complete view on our data, reducing experiment duplication, sharing data across the organization and freeing scientists from report creation, giving them back vital research hours. "
Hector Sanchez
Senior Director R&D Informatics, UCB